@UlarSawa I am not involved in this area. Maybe my colleagues are. Even if i had the data, i am not allowed to share it here as it is confidential.

@UlarSawa The government has set a target of 70% to achieve herd immunity. Efficacy of the vaccine is one thing, effectiveness is another. Efficacy in this case can be defined as the performance of an vaccines under ideal and controlled circumstances (ie. clinical trials), whereas effectiveness refers to its performance under 'real-world' conditions. So far, based on my research, only China vaccine has been verified as Halal. I could not find any info regarding the halal status of western vaccines., including Pfizer vaccine. Think about it, Malaysia being a muslim majority country, halal vaccines is a big deal in order to ensure EFFECTIVENESS through vaccine acceptance and compliance as covid vaccination will not be mandatory in Malaysia. So in order to achieve 70% vaccination, vaccine acceptance and compliance is important.

@UlarSawa Western countries have always been biased towards vaccines from non western countries all this while despite many non western countries producing vaccines which are on par with western countries and pre-qualified by WHO. Malaysia has approved many vaccines from non western countries which have been pre-qualified by WHO. So far, no issues.

@UlarSawa Of course i dare. WHO pre-qualification is international standard which is on par with FDA or Europeann Medicines Agency. Inactivated vaccine technology is tried and tested and proven to be the safest compared to new technologies mRNA or Adenovirus vector vaccine technology. I would definitely recommend my family to use inactivated vaccine technology. If you want to be the guinea pig for new vaccine technology, be my guest. Long term side effects can only be detected months or even years after the vaccine has been marketed worldwide. I wouldnt want to be part of the statistics of rare side effects.

@UlarSawa Hello, i work for the ministry of health, so i know the requirements zzzz....... If you do not know the requirements, please do not comment.....Yes we have approved many vaccines based on WHO pre-qualification alone without FDA or European Medicines Agency approval prior to this.

MoH to ensure Covid-19 vaccine fulfills WHO requirements — Health D-G

https://www.theedgemarkets.com/article/moh-ensure-covid19-vaccine-fulfils-who-requirements-%E2%80%94-health-dg

@UlarSawa Did you read my sharing above? As i mentioned Malaysia also accepts World Health Organization pre-qualification of vaccines, not just US FDA or European Medicines Agency.

China Poised to Be First to Distribute Virus Vaccine in Latin America, U.S. Official Says

https://www.nytimes.com/2020/12/02/us/politics/coronavirus-southern-command-china-latin-america.html

China has timely released the latest vaccines information, China’s vaccines are gaining international steam and a growing number of states are following up to obtain them. Whilst the achievements of Moderna and Pzifer are widely lauded, in the end, these companies only complete a part of the jigsaw in ending the COVID-19 crisis. Not everyone has the privilege or infrastructure to buy them. Therefore, the accomplishment of SinoVac, CanSino, and SinoPharm are set to play a significant role in making a difference for billions of people around the world.

https://moderndiplomacy.eu/2020/12/02/covid-19-vaccine-a-mutual-partnership-between-morocco-and-china/

Chinese vice premier underlines progress in COVID-19 vaccine development

BEIJING, Dec. 2 (Xinhua) -- Vice Premier Sun Chunlan on Wednesday said China has achieved major progress in the research and development of COVID-19 vaccines, with five vaccines having entered phase-III clinical trials.

Sun made the remarks as she and State Councilor Wang Yong inspected the work on COVID-19 vaccine development and production in Beijing.

Sun said 14 vaccines developed from five technological routes have entered clinical trials, five of which have entered phase-III clinical trials.

Emergency use and preparation for the production of the vaccines are progressing smoothly, she said.

Sun called for consistent efforts to carry out phase-III clinical trials of the vaccines with a scientific and rigorous approach, and ensure they meet relevant laws and regulations and international standards.

The vaccines should be developed safely and effectively and be able to withstand tests in various aspects, she noted.

Efforts should go into the preparation for mass production and the drafting of distribution plans when the vaccines are available for the public, Sun said.

http://www.xinhuanet.com/english/2020-12/03/c_139559034.htm

Chinese COVID-19 vaccine 'shows no serious side effects' in Turkey

https://news.cgtn.com/news/2020-12-02/Chinese-COVID-19-vaccine-shows-no-serious-side-effects-in-Turkey-VTHKhX6yxq/index.html

Chinese COVID-19 vaccine 'shows no serious side effects' in Turkey

https://news.cgtn.com/news/2020-12-02/Chinese-COVID-19-vaccine-shows-no-serious-side-effects-in-Turkey-VTHKhX6yxq/index.html

Sinopharm is one of the best companies that exist worldwide. It is the seventh largest producer of vaccines internationally. The vaccine that we have chosen is an inactivated one, it is one of the most conventional and safest methods. It is like the flu vaccine, the polio vaccine and the diphtheria vaccine. Those are inactivated vaccines that have been effective for years and years", he added.

https://www.africanews.com/2020/12/02/morocco-end-of-year-vaccination-plans-criticized/

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

US says Covid-19 vaccines ready to be shipped nationwide immediately

https://www.freemalaysiatoday.com/category/world/2020/12/02/us-says-covid-19-vaccines-ready-to-be-shipped-nationwide-immediately/

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Morocco is looking to register the Russian Sputnik V vaccine and will likely be a key manufacturer and distributor of the Chinese Sinopharm vaccine.

https://www.moroccoworldnews.com/2020/12/327636/uk-approves-covid-19-vaccine-for-use-scramble-for-vaccines-begins/

Galvez added during the government's Laging Handa briefing that his group is also in talks with China's Sinopharm, which could also produce vaccines in the next three months.

https://cnnphilippines.com/news/2020/12/2/PH-COVID-19-vaccine-supply-Sinovac-Gamaleya-Q1-2021.html

Egypt begins process to contract 20 million doses of COVID-19 vaccine

In addition to developing its own vaccine, Egypt’s VACSERA struck a deal in September with China’s Sinopharm to conduct human trials of the Chinese company’s vaccine. No reports have been released from these trials.

https://www.egyptindependent.com/egypt-contracts-20-million-doses-of-covid-19-vaccines/

Kanger's core bamboo business will be on track to making profit with the bright outlook on China's economic growth in 2021

--------------------

OECD lifts global economic outlook on vaccine progress, sees China driving recovery

China to drive global recovery

The OECD said the economic recovery would be uneven across countries, however, “potentially leading to lasting changes in the world economy.”

It said China was expected to account for over one-third of world economic growth in 2021, while the contribution of Europe and North America “will remain smaller than their weight in the world economy.”

The OECD said it sees China, which started recovering earlier than its peers, recording economic growth of 1.8% this year. It remains the only major economy expected to record economic growth in 2020.

The world’s second-largest economy was projected to record real GDP growth of 8% next year and 4.9% in 2022.

By comparison, the U.S. was expected to record an economic contraction of 3.7% in 2020, before posting growth of 3.2% in 2021 and 3.5% in 2022.

The euro area was seen reporting real GDP of -7.5% this year, 3.6% in 2021 and 3.3% in 2022.

“Despite the huge policy band-aid, and even in an upside scenario, the pandemic will have damaged the socio-economic fabric of countries worldwide,” the OECD said in its report.

“People living in poverty and usually less well covered by social safety nets have seen their situation deteriorate even further. Children and youth from less well-off backgrounds, and less qualified adult workers have struggled to learn and work from home, with potentially long lasting damage.”

The OECD said governments would need to use their policy instruments to actively ensure those hit hardest by the coronavirus crisis receive the support they need.

https://www.cnbc.com/2020/12/01/world-economy-oecd-lifts-outlook-on-vaccine-progress-sees-china-driving-recovery.html

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Noor Hisham says no to emergency use of Covid-19 vaccine, after UK move

PUTRAJAYA: Health director-general Dr Noor Hisham Abdullah has clarified that the government will not approve the Pfizer Covid-19 vaccine for emergency use in Malaysia.

His comments come after the UK government authorised the vaccine for emergency cases earlier today, becoming the first country in the world to do so.

“The Medicines and Healthcare products Regulatory Agency in the UK has approved the use of the vaccine, but that does not mean it has been registered. They are only using it for emergencies.

“In Malaysia, we will not make any exceptions to use the vaccine for emergencies. This is to ensure the safety of all,” he said at a press conference today.

Prime Minister Muhyiddin Yassin said regulatory clearance from the US Food and Drug Administration and Malaysia’s National Pharmaceutical Regulatory Agency will be required before the vaccine can be used here.

https://www.freemalaysiatoday.com/category/nation/2020/12/02/noor-hisham-says-no-to-emergency-use-of-covid-19-vaccine-after-uk-move/

Here it states that Kanger's target commencement date for producing gloves is Q1 2021. Cant find any other recent information regarding this.

https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deployment-could-generate-demand-18-billion-pieces-gloves-year

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

@Jjkcl True but Malaysia will still need to wait for FDA approval before we can proceed to assess the data and approve it for local use.